Top Banner
M.R.A. Pillai Ph.D.; D.Sc Molecular Group of Companies, Cochin [email protected] https://independent.academia.edu/PillaiM RA Clinical Utilization of Re-188 Radiopharmaceuticals: Issues and solutions
34

Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

May 14, 2023

Download

Documents

Pillai M.R.A.
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

M.R.A. Pillai Ph.D.; D.ScMolecular Group of Companies, Cochin

[email protected]://independent.academia.edu/PillaiMRA

Clinical Utilization of Re-188

Radiopharmaceuticals:Issues and solutions

Page 2: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India
Page 3: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Slide from Dr. R. Baum

Page 4: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

177Lu and 90Y can be mass produced

Lutetium-177◦176Lu(n,g)177Lu

Specific activity >20 Ci/mgYttirum-90◦90Sr/90Y generator◦Large inventory of 90Sr◦Annual Production 600 Mega Curie

Production of long lived parent radionuclides for generators : 68Ge, 82Sr, 90Sr and 188W. (IAEA 2010)

Page 5: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Yttrium-90 Different technologies are available for the separation of 90Y from 90Sr

The electrochemical generator ‘Kamadhenu’ can provide a continuous source of 90Y from a single source of 90Sr

Page 6: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Current Status in India

90Y is not locally available 90Y microspheres for TARE can be imported at a cost of 0.6 million INR equivalent to ~ 10,000 USD

Thus the interest in 188Re as a cost effective alternative despite no local production of 188W or W/Re generator in India

188Re is a very useful till there is wider availability of 90Y.

Page 7: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

There are three issues in the wider use of 188Re◦Availability of 188W◦Preparation of column generator◦Radiopharmaceuticals development

Page 8: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

1. Production of 188W

Reactor production and processing of 188W. Knapp et al. 2010

Annual Production capacity 500-1000 CiEquivalent to 500-1000 generatorsSpecific activty 4-5 Ci/g

Page 9: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

2. Column Generator

Page 10: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Issues with Column Generator Production 188W maximum specific activity is 4-5 Ci/g

Capacity of alumina for 188Re <50 mg/g2 g alumina can take ~ 400-500 mCi of activity

Generator with capacity >500 mCi will result in large elution volume.

Post elution concentration is an option; but a difficult option and not preferred

Page 11: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Nano crystalline Titania : 300 mg/g Nanocrystalline Zirconia : 325 mg/gNanocrystalline Alumina : 500 mg/g

Nano Alumina as column Matrix

Page 12: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

1 g of nano-alumina generator can load >2 Ci of 188W

Low elution volume and high concentration eluent

Extended use of generator Nanoalumina based generator are acceptable to regulators

Page 13: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Logistics of Gamma Alumina based Generators

Page 14: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Elution profile of Nano alumina Column generator

Page 15: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Radio-rheniums

185Re(n,g)186Re; s 114 barns187Re(n,g)188Re; s 72 barnsMultivalent and versatile chemistry

15

Page 16: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Mixed Radionuclide Therapy

A natural rhenium target when irradiated for 7 days reactor gives a mixture of 186Re and 188Re at ~40:60 ratio:

A day cooling will yield a mixture of 60:40.

Both the radionuclides are useful for therapy

Page 17: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

3. Rhenium ChemistryTechnetium and rhenium has identical chemical properties

Hence most technetium complexes can be duplicated with rhenium

The above statements are true to some extent; but miserably fail once we start exploring

the chemistry

Page 18: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India
Page 19: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India
Page 20: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Products developed

186/188Re-HEDP186/188Re-CTMP186/188Re-DMSA(Sn)186/188Re-DMSA(MBS)186/188Re-HA particles186/188Re-EC

Page 21: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

• Natural rhenium metal irradiated for 7 days; followed by 4 days cooling•Dissolution in HNO3, evaporation and addition of ammonia to convert to ammonium perrhenate, poor complexation •Extraction in MEK and dissolution in saline improves the complexation efficiency

Page 22: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

186/188Re-HEDP50 mg HEDP10 mg SnCl2100 mg rhenium carrierPerrhenate (NaReO4)Complexation at pH 2, 100oCStorage upto 4 days at pH 2 and at 4oC

Adjusting the pH to 8 reduces the kidney dose

Bone uptake ~30% at 48 h p.i.

Page 23: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India
Page 24: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India
Page 25: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

99mTc(V)DMSA for imaging medullary thyroid carcinoma

188Re(V)DMSA for treatment of medullary thyroid carcinoma

High renal uptake Metastatic bone pain palliation

Page 26: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India
Page 27: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India
Page 28: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

186/188Re-DMSA with different reducing agents: Stannous chloride and Sodium metabisulphite

Page 29: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India
Page 30: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India
Page 31: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Locoregional injection retained >98% of the activity in the knee joint

Page 32: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India
Page 33: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

ConclusionsThe limitations w.r.t 188W production and availability will continue

Nano-alumina based column generator will be advantageous

188Re-HEDP could be a readily available radiopharmaceutical for bone pain palliation.

188Re-CTMP might be better than 188Re-HEDP; and worth exploring

188Re-DMSA is useful for medullary thyroid carcinoma.

Depending upon the method of production; rhenium complexes could be different and hence need careful evaluation

Page 34: Rhenium Radiopharmaceuticals: Products Having Potential to Move from Bench to Bedside-1st World Rhenium Conference 11-13, KMCH, Coimbatore, India

Thank you